Abstract:Antithrombin (AT) is a heparin-binding serpin in plasma which regulates the proteolytic activity of procoagulant proteases of the clotting cascade. In addition to being an anticoagulant, AT also exhibits antiinflammatory activities when it binds to cell surface heparan sulfate proteoglycans (HSPGs) on the endothelium via its basic residues of D-helix to elicit intracellular signalling responses. By contrast to AT, α1-proteinase inhibitor (α1-PI) is a non-heparin-binding serpin that exhibits very slow reactivity with coagulation proteases and possesses no HSPG-dependent antiinflammatory properties. To determine whether the antiinflammatory signaling specificity of AT can be transferred to α1-PI, we replaced the D-helix of human α1-PI with the corresponding sequence of human AT and expressed the chimeric serpin α1-PI/D-helix) in a bacterial expression system. High molecular weight heparin bound to α1-PI/D-helix and accelerated the inhibition of thrombin by the serpin mutant by a template mechanism reminiscent of the cofactor effect of heparin on inhibition of thrombin by AT. Like AT, α1-PI/D-helix exhibited antiinflammatory properties in both cellular and animal models. Thus, α1-PI/D-helix inhibited the barrier-disruptive effect of proinflammatory cytokines and inhibited the activation of nuclear factor-κB transcription factor in lipopolysaccharide-stimulated endothelial cells by a concentration-dependent manner. Furthermore, the chimeric serpin reduced lipopolysaccharide-mediated lethality, elicited a vascular protective effect and inhibited infiltration of activated leukocytes to the peritoneal cavity of mice in an HMGB1-mediated inflammatory model. These results suggest that grafting the D-helix of AT to α1-PI confers antiinflammatory properties on the serpin and that the chimeric serpin may have therapeutic utility for treating inflammatory disorders.

Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain

[Progresses in the Structure and Function of Kazal-type Proteinase Inhibitors].

Structure and function of invertebrate Kazal-type serine proteinase inhibitors

Mechanistic study on the anti-proinflammatory activity of Kunitz type inhibitor from Caesalpinia decapetala seeds

Two Kazal-Type Protease Inhibitors from Macrobrachium Nipponense and Eriocheir Sinensis: Comparative Analysis of Structure and Activities

Contribution of conserved Asn residues to the inhibitory activities of Kunitz-type protease inhibitors from plants

Advancements in Serine Protease Inhibitors: From Mechanistic Insights to Clinical Applications

Inhibition of Plasminogen Activation by a Kunitz Inhibitor, Aprotinin

Serine proteases of the human immune system in health and disease

Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)

The Inhibitor Effect of RKIP on Inflammasome Activation and Inflammasome-Dependent Diseases

A Concise Review of Some Clinically Relevant Interactions

Modulation of Serpin Reaction Through Stabilization of Transient Intermediate by Ligands Bound to Α-Helix F

The under‐appreciated world of the serpin family of serine proteinase inhibitors

Endogenous anti-inflammatory substances, inter-α-inhibitor and bikunin

Biological activities of Vipegrin, an anti-adhesive Kunitz-type serine proteinase inhibitor purified from Russell's viper venom

Purification and Biochemical Characterization of a New Protease Inhibitor from Conyza dioscoridis with Antimicrobial, Antifungal and Cytotoxic Effects

Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation

Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases

Engineering D-helix of antithrombin in alpha-1-proteinase inhibitor confers antiinflammatory properties on the chimeric serpin

Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers